FMP
NASDAQ
1.79 USD
0.01 (0.559%)
Mr. Antoine Awad
Healthcare
Biotechnology
https://www.synlogictx.com
NASDAQ
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate to treat homocystinuria; and SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase I clinical trial for the treatment of enteric hyperoxaluria. The company is also developing SYNB1891, an intratum...
0001527599
US87166L2097
87166L100
301 Binney Street
617 401 9975
US
6
Sep 30, 2015
0001527599
NASDAQ
Biotechnology
Healthcare
87166L100
US87166L2097
US
1.79
1.09
139.82k
20.85M
-
0.234-5.708
1.36
-
-
-
-
-0.2
-
https://www.synlogictx.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.